Gut Microbiota Profile in Patients With Nonalcoholic Fatty Liver Disease and Presumed Nonalcoholic Steatohepatitis Publisher



Mohammadi Z¹ ; Poustchi H¹ ; Hekmatdoost A² ; Etemadi A³ ; Eghtesad S¹ ; Sharafkhah M¹ ; Stewart D⁴ ; Ghanbari R⁵ ; Chlipala GE⁶ ; Bishehsari F⁷ ; Merat S⁸ ; Malekzadeh R⁵ Show Affiliations
Source: Journal of Research in Medical Sciences Published:2022

Abstract

Background: The main composition of intestinal microbiota in nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) patients has not yet been elucidated. In this, case‑control study, we identified differences of intestinal microbiota in male patients with NAFLD, presumed NASH, and healthy controls. Materials and Methods: We compared gut microbial composition of 25 patients with NAFLD, 13 patients with presumed NASH, and 12 healthy controls. Demographic information as well as clinical, nutritional, and physical activity data was gathered. Stool and blood samples were collected to perform the laboratory analysis. The taxonomic composition of gut microbiota was assessed using V4 regions of microbial small subunit ribosomal Ribonucleic acid genes sequencing of stool samples. Results: Firmicutes, Actinobacteria, and Bacteroidetes were the most frequently phyla in all groups. Our results revealed that Veillonella was the only genus with significantly different amounts in presumed NASH patients compared with patients with NAFLD (P = 2.76 × 10−6, q = 2.07 × 10−4, logFC = 5.52). Conclusion: This pilot study was the first study to compare gut microbial composition in patients with NAFLD and presumed NASH in the Middle East. Given the potential effects of gut microbiota on the management and prevention of NAFLD, larger, prospective studies are recommended to confirm this study’s findings. © 2022 Journal of Research in Medical Sciences | Published by Wolters Kluwer - Medknow.